Ipf Incidence And Prevalence 2024 Worldwide 2024. Current estimates of fungal disease incidence and mortality are imprecise. The global market for idiopathic pulmonary fibrosis estimated to attain $11.7 billion by 2031, growing at cagr 7.3% over the forecast period, driven by dramatically.
According to these prevalence estimates, ipf remains a rare. While both drugs slowed down lung function decline in idiopathic pulmonary fibrosis (ipf), they were also linked to more deaths and increased incidence of acute.